Atlas Trials

The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI

Clinical trial NCT05511831 · UNKNOWN

Trial details

NCT number
NCT05511831
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ST-segment Elevation Myocardial Infarction (STEMI)
Start date
2022-09-01
Primary completion
2023-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.